(Q43208675)

16 November 2017

title

Long-term results of Tokyo Children's Cancer Study Group trials for childhood acute lymphoblastic leukemia, 1984-1999. (English)

1 reference

16 November 2017

1 reference

lymphoblastic leukemia

1 reference

20

1 reference

16 November 2017

3

A Manabe

1 reference

16 November 2017

M Tsuchida

1

1 reference

16 November 2017

A Ohara

2

1 reference

16 November 2017

M Kumagai

4

1 reference

16 November 2017

H Shimada

5

1 reference

16 November 2017

A Kikuchi

6

1 reference

16 November 2017

T Mori

7

1 reference

16 November 2017

M Saito

8

1 reference

16 November 2017

M Akiyama

9

1 reference

16 November 2017

T Fukushima

10

1 reference

16 November 2017

K Koike

11

1 reference

16 November 2017

M Shiobara

12

1 reference

16 November 2017

C Ogawa

13

1 reference

16 November 2017

T Kanazawa

14

1 reference

16 November 2017

Y Noguchi

15

1 reference

16 November 2017

S Oota

16

1 reference

16 November 2017

Y Okimoto

17

1 reference

16 November 2017

H Yabe

18

1 reference

16 November 2017

M Kajiwara

19

1 reference

16 November 2017

K Ko

21

1 reference

16 November 2017

K Sugita

22

1 reference

16 November 2017

T Kaneko

23

1 reference

16 November 2017

M Maeda

24

1 reference

16 November 2017

T Inukai

25

1 reference

16 November 2017

H Goto

26

1 reference

16 November 2017

H Takahashi

27

1 reference

16 November 2017

K Isoyama

28

1 reference

16 November 2017

Y Hayashi

29

1 reference

16 November 2017

R Hosoya

30

1 reference

16 November 2017

R Hanada

31

1 reference

16 November 2017

Tokyo Children's Cancer Study Group

32

1 reference

16 November 2017

publication date

24 December 2009

1 reference

16 November 2017

1 reference

16 November 2017

volume

24

1 reference

16 November 2017

issue

2

1 reference

16 November 2017

page(s)

383-396

1 reference

Childhood acute lymphocytic leukemia. Study VIII

16 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

No advantage of dexamethasone over prednisolone for the outcome of standard- and intermediate-risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study Group L95-14 protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

Moyamoya syndrome following childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: results of an Austrian-German multicenter longitudinal study and im

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

Treating childhood acute lymphoblastic leukemia without cranial irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

Long-term follow-up of childhood acute lymphoblastic leukemia in Tokyo Children's Cancer Study Group 1981-1995

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

7 January 2021

[Treatment of acute lymphoblastic leukemia in childhood and adolescence: results of the multicenter therapy study ALL-BFM 81]

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

7 January 2021

Delay of the diagnostic lumbar puncture and intrathecal chemotherapy in children with acute lymphoblastic leukemia who undergo routine corticosteroid testing: Tokyo Children's Cancer Study Group study L89-12.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

7 January 2021

Six months of maintenance chemotherapy after intensified treatment for acute lymphoblastic leukemia of childhood

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

7 January 2021

Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Ital

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

7 January 2021

Sex differences in prognosis for children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

7 January 2021

Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

7 January 2021

Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

7 January 2021

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

7 January 2021

Infant leukemia in Japan: clinical and biological analysis of 48 cases

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

7 January 2021

Clinical and biological aspects of acute lymphoblastic leukemia in 62 infants: retrospective analysis of the Tokyo Children's Cancer Study Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

7 January 2021

Intermediate dose methotrexate is as effective as high dose methotrexate in preventing isolated testicular relapse in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

7 January 2021

Allogeneic bone marrow transplantation in first remission rescues children with Philadelphia chromosome-positive acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) studies L89-12 and L92-13

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

7 January 2021

Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

7 January 2021

[Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)]

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.260

7 January 2021

Identifiers

DOI

10.1038/LEU.2009.260

1 reference

Dimensions Publication ID

16 November 2017

1038099959

0 references

1 reference